Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

VISTIN PHARMA Aktie

>VISTIN PHARMA Performance
1 Woche: 0%
1 Monat: -6,3%
3 Monate: -1,9%
6 Monate: +5,6%
1 Jahr: +11,2%
laufendes Jahr: +6,1%
>VISTIN PHARMA Aktie
Name:  VISTIN PHARMA ASA NK 1
Land:  Norwegen
Sektor:  Gesundheit
ISIN/ Wkn:  NO0010734122 / A14TLR
Symbol/ Ticker:  VP4 (Frankfurt)
Kürzel:  FRA:VP4, ETR:VP4, VP4:GR
Index:  -
Webseite:  https://www.vistin.com/
Marktkapitalisierung:  93.61 Mio. EUR
Umsatz:  381.52 Mio. EUR
EBITDA:  97.87 Mio. EUR
Gewinn je Aktie:  0.13 EUR
Schulden:  1.73 Mio. EUR
Liquide Mittel:  10.97 Mio. EUR
Umsatz-/ Gewinnwachstum:  10.7% / 183.4%
KGV/ KGV lG:  13.83 / -
KUV/ KBV/ PEG:  2.42 / 3.22 / -
Gewinnm./ Eigenkapitalr.:  17.43% / 24.44%
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / 5.17%
Div. Historie:  05.06.24 - 0.0435€
21.05.21 - 0.04924€
Insiderhandel:  -
Suchwörter:  VISTIN PHARMA
Letzte Datenerhebung:  05.07.25
>Eigentümer
Aktien: 44.34 Mio. St.
f.h. Aktien: 23.75 Mio. St.
Insider Eigner: 56.33%
Instit. Eigner: 12.54%
Leerverk. Aktien: -
>Peer Group

 
04.06.25 - 08:03
 Ex dividend NOK 1.25 today (GlobeNewswire EN)
 
The shares in Vistin Pharma ASA (VISTN) will be traded ex dividend NOK 1.25 as from today, 04.06.2025....
02.06.25 - 23:42
 XFRA: DIVIDEND/INTEREST INFORMATION - 04.06.2025 - EQUBF_01 (XETRA)
 
Das Instrument VP4 NO0010734122 VISTIN PHARMA ASA NK 1 EQUITY wird cum Dividende/Zinsen gehandelt am 03.06.2025 und ex Dividende/Zinsen am 04.06.2025 The instrument VP4 NO0010734122 VISTIN PHARMA ASA NK 1 EQUITY has its pre-dividend/interest day on 03.06.2025 and its ex-dividend/interest day on 04.06.2025...
22.05.25 - 12:00
 Disclosure of voting rights at AGM in Vistin Pharma ASA (GlobeNewswire EN)
 
Oslo, Norway, 22 May 2025...
06.05.25 - 15:06
 Vistin Pharma ASA (VISTN): Mandatory notification of trade and disclosure of large shareholding (GlobeNewswire EN)
 
Ferncliff Listed Dai AS has on 6 May 2025 sold 1,234,280 shares in Vistin Pharma ASA at NOK 22.50 per share....
25.04.25 - 16:42
 2024 Annual Report Vistin Pharma ASA (GlobeNewswire EN)
 
Oslo, Norway, 25 April 2025...
25.04.25 - 07:36
 Vistin Pharma ASA: First quarter 2025 financial results (GlobeNewswire EN)
 
Oslo, Norway, 25th of April 2025...
15.04.25 - 13:03
 Vistin Pharma ASA: Invitation to Q1 2025 conference call (GlobeNewswire EN)
 
Oslo, Norway, 15 April 2025...
13.02.25 - 12:03
 Vistin Pharma ASA: Key information relating to the proposed cash dividend (GlobeNewswire EN)
 
The Board of Directors of Vistin Pharma ASA (VISTN) will propose to distribute a cash dividend of total NOK 1.25 per share, to be paid in June, for the accounting year of 2024. The formal decision regarding the dividend will be made on the company's Annual General Meeting, which will be held on 22 May 2025....
06.02.25 - 11:03
 Vistin Pharma ASA: Invitation to Q4 2024 conference call (GlobeNewswire EN)
 
Oslo, Norway, 6 February 2025...
06.11.24 - 07:48
 Ex dividend NOK 0.50 today (GlobeNewswire EN)
 
The shares in Vistin Pharma ASA will be traded ex dividend NOK 0.50 as from today, 06.11.2024....
04.11.24 - 23:58
 XFRA : CAPITAL ADJUSTMENT INFORMATION - 06.11.2024 - NO0010734122 (XETRA)
 
Das Instrument VP4 NO0010734122 VISTIN PHARMA ASA NK 1 EQUITY wird cum Kapitalmassnahme gehandelt am 05.11.2024 und ex Kapitalmassnahme am 06.11.2024 The instrument VP4 NO0010734122 VISTIN PHARMA ASA NK 1 EQUITY is traded cum capital adjustment on 05.11.2024 and ex capital adjustment on 06.11.2024...
31.10.24 - 07:42
 Vistin Pharma ASA: Third quarter and YTD 2024 financial results (GlobeNewswire EN)
 
Oslo, Norway, 31st of October 2024...
24.10.24 - 10:06
 Vistin Pharma ASA: Invitation to Q3 2024 conference call (GlobeNewswire EN)
 
Oslo, Norway, 24 October 2024...
26.09.24 - 17:30
 Vistin Pharma ASA: Mandatory notification of trade (GlobeNewswire EN)
 
Saga Pure ASA has on 26 September 2024 purchased 50,000 shares in Vistin Pharma ASA at NOK 28.2 per share. After the transaction Saga Pure ASA has a holding of 700,000 shares, corresponding to 1.58% ownership.Saga Pure ASA is closely associated with board member Øystein Stray Spetalen....
13.09.24 - 17:12
 Disclosure of large shareholding and mandatory notification of trade in Vistin Pharma ASA (GlobeNewswire EN)
 
Saga Pure ASA has on 13 September 2024 purchased 250,000 shares in Vistin Pharma ASA at NOK 25.13 per share. After the transaction Saga Pure ASA has a holding of 650,000 shares, corresponding to 1.47% ownership. Saga Pure ASA is closely associated with board member Øystein Stray Spetalen....
23.08.24 - 16:09
 Vistin Pharma ASA: Mandatory notification of trade (GlobeNewswire EN)
 
Saga Pure ASA has on 23 August 2024 purchased 300,000 shares in Vistin Pharma ASA at NOK 22,50 per share. After the transaction Saga Pure ASA has a holding of 400,000 shares, corresponding to 0.9 % ownership. Saga Pure ASA is closely associated with board member Øystein Stray Spetalen....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Kein Kaiser kann, was unser ist, verschenken. - Friedrich Johann Christoph Schiller
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!